Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 6Recruiting 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Recurrence 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Liver Neoplasms 1Intraoral Tumor 1Esophageal Neoplasms 1Disease Progression 1Chalazion 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Brain Edema 1

Interventions

Blood Specimen Collection 38pembrolizumab 36Bevacizumab 22Surveys and Questionnaires 18Standard of Care 18Radiotherapy 18Exercise 17Carboplatin 16Nivolumab 15atezolizumab 14Cisplatin 14Drug Therapy 13Paclitaxel 12Fluorouracil 12Cyclophosphamide 12Cetuximab 12Trastuzumab 10Leucovorin 10Docetaxel 10Dexamethasone 10Pemetrexed 9Oxaliplatin 9Biopsy 9pertuzumab 8olaparib 8Temozolomide 8Panitumumab 8Observation 8Irinotecan 8abemaciclib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms × Sevoflurane × Clear all
NCT04800393 2023-04-26

TeMP

Moscow Clinical Scientific Center

Phase NA Recruiting
130 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡